학술논문

COVID‐19 in vaccinated versus unvaccinated hematologic malignancy patients
Document Type
article
Source
Transplant Infectious Disease. 24(6)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Vaccine Related
Immunization
Hematology
Cancer
Rare Diseases
Clinical Research
Humans
COVID-19
Retrospective Studies
Hematologic Neoplasms
Logistic Models
Vaccination
breakthrough infection
hematologic malignancy
Surgery
Clinical sciences
Language
Abstract
The effect of vaccination on severity of subsequent COVID-19 in patients with hematologic malignancies (HMs) is unknown. In this single-center retrospective cohort study, we found no difference in severity of COVID-19 disease in vaccinated (n = 16) versus unvaccinated (n = 54) HM patients using an adjusted multiple logistic regression model. Recent anti-B-cell therapy was associated with more severe illness.